BIT
IOVA icon

BlackRock Institutional Trust’s Iovance Biotherapeutics IOVA Stock Holding History

BlackRock Institutional Trust’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$8.81M Buy
1,268,264
+41,240
+3% +$284K ﹤0.01% 2465
2016
Q3 		$10.1M Buy
1,227,024
+85,823
+8% +$726K ﹤0.01% 2326
2016
Q2 		$9.24M Buy
1,141,201
+14,415
+1% +$90.5K ﹤0.01% 2334
2016
Q1 		$5.72M Sell
1,126,786
-3,719
-0.3% -$20.4K ﹤0.01% 2588
2015
Q4 		$8.73M Buy
1,130,505
+54,526
+5% +$378K ﹤0.01% 2414
2015
Q3 		$6.2M Buy
1,075,979
+37,936
+4% +$295K ﹤0.01% 2596
2015
Q2 		$9.52M Buy
1,038,043
+895,736
+629% +$10M ﹤0.01% 2438
2015
Q1 		$1.72M Buy
+142,307
New +$1.6M ﹤0.01% 3178

Other funds holding IOVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Institutional Trust's IOVA Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Iovance Biotherapeutics (IOVA) stake by 3.4% in Q4 2016, buying an estimated $284K and bringing the position to 1,268,264 shares worth $8.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2465.

BlackRock Institutional Trust first reported a position in IOVA in Q1 2015 and has held it in 8 quarters since. The position peaked at $10.1M in Q3 2016. 87 funds tracked by Wall St. Rank hold IOVA as of Q4 2016.

  • BlackRock Institutional Trust held 1,268,264 shares of Iovance Biotherapeutics worth $8.81M as of Q4 2016.
  • BlackRock Institutional Trust bought 41,240 Iovance Biotherapeutics shares in Q4 2016, an estimated $284K.
  • Iovance Biotherapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2465 holding.
  • BlackRock Institutional Trust first reported a position in Iovance Biotherapeutics in Q1 2015 and has held it in 8 quarters since.
  • BlackRock Institutional Trust's Iovance Biotherapeutics position peaked at $10.1M in Q3 2016.
  • 87 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.